Cumberland shareholders re-elect three directors, ratify auditor with >98% votes

CUMBERLAND PHARMACEUTICALS INC

Directors Bernard, Galante, and Kazimi re-elected with 98.6%, 99.2%, and 99.6% votes in favor.
Auditor Carr, Riggs & Ingram ratified for 2025 with 99.7% votes in favor.
Annual meeting held April 22, 2025 in Nashville, Tennessee.

item 5.07

CUMBERLAND PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001628280-25-020222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.